What Is N-Acetyl Semax Amidate?
N-Acetyl Semax Amidate (NASA) is a chemically modified analog of the Russian nootropic peptide Semax, engineered with an N-terminal acetyl group and a C-terminal amide to resist enzymatic breakdown. These end-cap modifications are a standard way to slow peptide degradation, and vendors market the result as a longer-lasting, “more potent” version of Semax. It is sold as a research chemical, not as an approved drug or dietary supplement anywhere.
Evidence
There is essentially no independent, peer-reviewed clinical or animal literature on N-Acetyl Semax Amidate specifically. Almost all information about it comes from peptide vendors and nootropic communities, not from verifiable trials — I did not find a citable PubMed study on this exact compound in this pass. The general chemistry claim (that N-acetylation and C-terminal amidation increase resistance to peptidases and can extend a peptide’s half-life) is a well-established structure–activity principle, but that is a broad framing point, not evidence that this analog is safe or more effective than Semax in humans. Any claim that it is “more potent” than Semax is, at present, an extrapolation rather than a demonstrated finding. For the parent peptide’s (largely preclinical/Russian) evidence, see the Semax page.
Dosage & Safety
N-Acetyl Semax Amidate is an unapproved research chemical — not a medicine and not a dietary supplement — and this section is informational only, not a recommendation to use it. No reliable studied human dose range exists; figures circulated online come from vendors and users, not trials, and are not established. Because there is essentially no independent research on this specific analog, its safety profile, toxicity, drug interactions, contraindications, and use in pregnancy are entirely not characterised — absence of reported harm here reflects absence of study, not evidence of safety. Identity and purity of material sold under this name cannot be assumed.